Mycobacterium Tuberculosis Assay Morphotype Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tools for tuberculosis (TB) face challenges such as low specificity and sensitivity, particularly in resource-constrained countries, and lack a method to detect latent TB infection, requiring a more accurate, rapid, and cost-effective diagnostic solution that can be used in point-of-care settings.
Innovation Solution
Development of assays that exploit phase variation in Mycobacterium tuberculosis, utilizing molecules that selectively bind to rough-type and smooth-type morphotypes to differentiate between active and latent TB infections, enabling detection through various assay formats including lateral flow assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic tools (TST, sputum smear microscopy) are used, then the diagnostic process is simple and cost-effective, but sensitivity and specificity are low leading to false positives and negatives
Solution Approach 1:
The invention segments the detection process by targeting specific morphotypes (rough and smooth) of Mtb that are associated with different infection states. This segmentation allows differentiation between latent and active TB through distinct molecular markers, improving diagnostic precision without requiring complex equipment
Solution Approach 2:
The assay employs local quality by using morphotype-specific molecules that bind preferentially to either rough-type or smooth-type Mtb. This selective binding enables localized detection of specific infection states, enhancing both sensitivity and specificity while maintaining operational simplicity
2Measurement precision
If TB culture growth method is used, then definitive diagnosis is achieved, but the process takes up to two months
Solution Approach 1:
The invention performs preliminary action by detecting morphotype-specific molecules directly from clinical samples without requiring prolonged culture growth. This preliminary detection of rough-type and smooth-type Mtb markers provides rapid preliminary diagnosis within hours rather than months
Solution Approach 2:
The assay replaces the mechanical culture growth system with a molecular detection system that identifies Mtb through specific binding molecules. This substitution eliminates the need for lengthy incubation periods while maintaining diagnostic accuracy, reducing turnaround time from months to hours
3Measurement precision
If modern diagnostic technology is used, then accuracy and turnaround time are improved, but sophisticated equipment and trained personnel are required
Solution Approach 1:
The invention employs disposable assay kits containing pre-formulated binding molecules and detection reagents. These single-use kits eliminate the need for expensive, sophisticated equipment while maintaining high diagnostic accuracy, making the technology accessible in resource-limited settings
Solution Approach 2:
The assay is designed for self-service operation where the binding molecules automatically detect and bind to target morphotypes in the sample. This self-detecting mechanism requires minimal trained personnel and simplifies operational complexity while preserving diagnostic precision
4Measurement precision
If current skin and blood tests are used, then exposure to TB is detected, but latent infection cannot be distinguished
Solution Approach 1:
The invention segments infection detection by identifying distinct morphotypes: rough-type Mtb associated with latent infection and smooth-type Mtb associated with active infection. This segmentation preserves infection state information that conventional tests lose, enabling differentiation between latent and active TB
Solution Approach 2:
The assay uses local quality through morphotype-specific binding molecules that selectively detect either rough-type or smooth-type Mtb. This selective detection preserves critical information about the infection state, allowing clinicians to distinguish between latent and active TB based on which morphotype is detected
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution provides increased sensitivity and specificity for TB diagnosis, allowing for the detection of active and latent infections, potentially reducing the burden of TB in resource-limited settings and improving diagnostic accuracy.
Implementation Method 1
a first molecule that selectively binds to the rough-type mycobacterium or binds to a molecule preferentially secreted by the rough-type mycobacterium and a second molecule that selectively binds to the smooth-type mycobacterium
Data Source
AI summary
Provided herein is an assay for detecting a rough-type mycobacterium and a smooth-type mycobacterium in a sample, wherein the mycobacterium is Mycobacterium tuberculosis or Mycobacterium bovis. The assay comprises a first molecule that selectively binds to the rough-type mycobacterium or binds to a molecule preferentially secreted by the rough-type mycobacterium and a second molecule that selectively binds to the smooth-type mycobacterium or binds to a molecule preferentially secreted by the smooth-type mycobacterium. The first molecule and the second molecule are independently detectable. Also provided herein are corresponding methods for detecting a rough-type mycobacterium and a smooth-type mycobacterium in a sample and assays and methods for detecting tuberculosis infection in a sample.